|
시장보고서
상품코드
2024516
전기영동 장비 시장 보고서 : 제품 유형, 유형, 최종사용자, 지역별(2026-2034년)Electrophoresis Equipment Market Report by Product Type, Type, End User, and Region 2026-2034 |
||||||
세계의 전기영동 장비 시장 규모는 2025년에 21억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 31억 달러에 달하며, 2026-2034년에 CAGR 4.20%로 성장할 것으로 예측하고 있습니다. 바이오테크놀러지의 지속적인 발전, 맞춤형 의료에 대한 수요 증가, 유전성 질환의 유병률 증가, 연구 활동의 활성화, 그리고 전 세계 제약, 진단 및 학술연구 기관에서 제품 사용의 확대 등이 이러한 시장 추세를 지원하는 주요 요인으로 작용하고 있습니다.
전기영동 장치는 전하, 크기, 결합 친화도에 따라 분자를 분리하거나 정제하는 데 사용되는 실험실 장비입니다. 전류를 끝에서 끝까지 흐르게 하여 핵산, 플라스미드, 데옥시리보핵산(DNA), 리보핵산(RNA), 단백질 및 이들 고분자의 단편과 같은 거대 분자를 분석하는 데 널리 사용되고 있습니다. 전기영동 장치는 한쪽 끝에 음극, 다른 쪽 끝에 양극이 있는 단단한 플라스틱 상자 또는 탱크로 구성된 전기영동 탱크를 사용하여 제조됩니다. 백신, 항체 분석, 헤모글로빈 질환, 의약품 품질관리 등 다양한 용도로 사용되고 있습니다. 그 결과, 전기영동 장치는 DNA의 기원을 규명하거나 단백질 분자를 조작하기 위해 법의학 조사, 분자생물학, 유전학, 미생물학 실험실에서 폭넓게 활용되고 있습니다.
전기영동 장비 시장 동향:
전 세계에서 연구개발 활동이 크게 증가하면서 시장 전망이 밝아지고 있습니다. 전기영동 장비는 진행 중인 생물학적 연구 프로젝트와 신약 발견에 대한 노력이 증가함에 따라 매우 유용하게 활용되고 있습니다. 이에 따라 유전성 질환, 암 및 다양한 질병의 치료가 점점 더 복잡해지고 있는 것도 시장 성장을 촉진하고 있습니다. 또한 제약 산업에서 약물 함량 분석 및 식별, DNA 단편 연구, 항생제 및 백신 테스트 등 다양한 제제의 품질관리를 위해 본 제품이 널리 채택되고 있는 것도 시장 성장을 촉진하는 요인입니다. 이와 더불어, 미생물 검출 및 분리 과정에서 모세관 전기영동법의 활용이 확대되면서 시장 성장을 촉진하고 있습니다. 또한 COVID-19 팬데믹 상황에서 모세관 전기영동은 새로운 SARS-CoV-2 변종에 대한 비용 효율적인 식별 방법을 개발하기 위해 모세관 전기영동이 널리 채택되어 지역 시설에서 SARS-CoV-2 변종을 검사하고 추적할 수 있게 됨에 따라 시장 성장에 탄력을 받고 있습니다. 시장 성장에 박차를 가하고 있습니다. 이와는 별도로, 폴리 아크릴 아미드 겔 전기 영동에 마이크로 유체 전기 영동 플랫폼이 도입되어 매우 유망한 결과를 가져온 것도 시장 성장을 촉진하고 있습니다. 또한 규제 당국의 승인 증가와 혈청 및 소변에서 모노클로널 단백질을 검출 및 식별하는 데 사용되는 면역형질분석기기의 출시가 시장 성장에 긍정적인 영향을 미치고 있습니다. 기타 광범위한 연구개발(R&D) 활동, 의료 인프라 개선, 의약품 품질관리 및 공정 검증에 대한 다양한 정부 구상 시행 등의 요인도 시장 성장을 촉진할 것으로 예상됩니다.
이 보고서에서 답변하는 주요 질문:
- 세계 전기영동 장비 시장은 지금까지 어떻게 성장해 왔으며, 향후 수년간 어떻게 성장하는가?
- 세계의 전기영동 장비 시장 촉진요인, 억제요인 및 기회는 무엇인가?
- 주요 지역 시장은 어디인가?
- 가장 매력적인 전기영동 장비 시장을 형성하고 있는 국가는 어느 국가인가?
- 제품 유형별 시장 구성은?
- 용도별 시장 분석은 어떻게 이루어지는가?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 세계의 전기 영동 장비 시장의 경쟁 구조는 무엇인가?
- 세계의 전기영동 장비 시장의 주요 플레이어/기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 전기영동 장비 시장
제6장 시장 내역 : 제품 유형별
제7장 시장 내역 : 유형별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 촉진요인·억제요인·기회
제11장 밸류체인 분석
제12장 Porters Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.05.18The global electrophoresis equipment market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.20% during 2026-2034. The ongoing advancements in biotechnology, increased demand for personalized medicine, rising prevalence of genetic disorders, growing research activities, and expanding product applications in pharmaceuticals, diagnostics, and academic research institutions globally are some of the key factors supporting the market trends.
Electrophoresis equipment is a laboratory tool used to separate or purify molecules based on charge, size, and binding affinity. It is widely used to analyze large molecules, such as nucleic acids, plasmids, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and fragments of these macromolecules by passing an electric current from end to end. Electrophoresis equipment is manufactured using an electrophoretic chamber which consists of a hard plastic box or tank with a cathode at one end and an anode at the opposite end. It is used in various applications, including vaccines, antibody analysis, hemoglobinopathies, and drug quality control. As a result, electrophoresis equipment finds extensive applications in forensic investigation, molecular biology, genetics, and microbiological labs to identify source DNA and manipulate protein molecules.
Electrophoresis Equipment Market Trends:
A significant increase in research and development activities across the globe is creating a positive outlook for the market. Electrophoresis equipment is extensively helpful in the rising number of ongoing biological research projects and initiatives regarding novel medicine discovery. In line with this, the increasing complexities in the treatment of diseases, such as genetically transmitted diseases, cancer, and various disorders, are favoring the market growth. Moreover, the widespread product adoption in the pharmaceutical industry for quality control of various formulations by analyzing and identifying the drug content, studying DNA fragments, and testing antibiotics and vaccines are acting as another growth-inducing factor. Along with this, the increasing utilization of capillary electrophoresis in the process of microbial detection and separation is propelling the market growth. Additionally, the widespread adoption of capillary electrophoresis during the COVID-19 pandemic to develop a cost-effective identification approach for novel SARS-CoV-2 variants, allowing local facilities to test and track SARS-CoV-2 variations is providing an impetus to the market growth. Apart from this, the introduction of microfluidic electrophoresis platforms to polyacrylamide gel electrophoresis that offers highly promising results is facilitating the market growth. Furthermore, increasing approvals from the regulatory authorities and the launch of an immunotyping device used to detect and identify monoclonal proteins in serum and urine are positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, improvements in the healthcare infrastructure and the implementation of various government initiatives regarding pharmaceutical products' quality control and process validation, are anticipated to drive the market growth.
Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global electrophoresis equipment market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on product type, type and end user.
Product Type Insights:
- Gel Electrophoresis Systems
- Capillary Electrophoresis Systems
- Electrophoresis Accessories
The report has also provided a detailed breakup and analysis of the electrophoresis equipment market based on the product type. This includes gel electrophoresis systems, capillary electrophoresis systems, and electrophoresis accessories. According to the report, gel electrophoresis systems represented the largest segment.
Type Insights:
- Vertical Electrophoresis
- Horizontal Electrophoresis
End User Insights:
- Hospitals and Diagnostics Centers
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
The report has also provided a detailed breakup and analysis of the electrophoresis equipment market based on the end user. This includes hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment.
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for electrophoresis equipment. Some of the factors driving the North America electrophoresis equipment market growth included its extensive application in the pharmaceutical industry, several product innovations, extensive research and development activities, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global electrophoresis equipment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Cleaver Scientific Ltd., Edvotek Inc., Flinn Scientific Inc., Hoefer Inc. (Harvard Bioscience Inc.), Lonza Group AG, Lumex Instruments, Merck KGaA, Nova-Tech International Inc., PerkinElmer Inc., Qiagen N.V., SERVA Electrophoresis GmbH, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global electrophoresis equipment market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global electrophoresis equipment market?
- What are the key regional markets?
- Which countries represent the most attractive electrophoresis equipment markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on end user?
- What is the competitive structure of the global electrophoresis equipment market?
- Who are the key players/companies in the global electrophoresis equipment market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Electrophoresis Equipment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Gel Electrophoresis Systems
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Capillary Electrophoresis Systems
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Electrophoresis Accessories
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Type
- 7.1 Vertical Electrophoresis
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Horizontal Electrophoresis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Diagnostics Centres
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Academic and Research Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Pharmaceutical and Biotechnology Companies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bio-Rad Laboratories Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Cleaver Scientific Ltd.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Edvotek Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Flinn Scientific Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Hoefer Inc. (Harvard Bioscience Inc.)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Lonza Group AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Lumex Instruments
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Merck KGaA
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Nova-Tech International Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 PerkinElmer Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Qiagen N.V.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 SERVA Electrophoresis GmbH
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.14 Thermo Fisher Scientific Inc.
- 14.3.14.1 Company Overview
- 14.3.14.2 Product Portfolio
- 14.3.14.3 Financials
- 14.3.14.4 SWOT Analysis
- 14.3.1 Agilent Technologies Inc.
